Citation: Js. Cohen, Comment: comparison of FDA reports of patient deaths associated with sildenafil and injectable alprostadil - Reply, ANN PHARMAC, 35(9), 2001, pp. 1143-1143
Citation: Js. Cohen, Is sildenafil product information adequate to facilitate informed therapeutic decisions? (vol 35, pg 337, 2001), ANN PHARMAC, 35(6), 2001, pp. 786-786
Citation: Js. Cohen, Comparison of FDA reports of patient deaths associated with sildenafil andwith injectable alprostadil, ANN PHARMAC, 35(3), 2001, pp. 285-288
Citation: Js. Cohen, Is the sildenafil product information adequate to facilitate informed therapeutic decisions?, ANN PHARMAC, 35(3), 2001, pp. 337-342
Citation: Js. Cohen, Reexamination of over-the-barrier and tunneling ionization of the hydrogenatom in an intense field - art. no. 043412, PHYS REV A, 6404(4), 2001, pp. 3412
Authors:
Ivanova, PT
Cerda, BA
Horn, DM
Cohen, JS
McLafferty, FW
Brown, HA
Citation: Pt. Ivanova et al., Electrospray ionization mass spectrometry analysis of changes in phospholipids in RBL-2H3 mastocytoma cells during degranulation, P NAS US, 98(13), 2001, pp. 7152-7157
Authors:
Sterin, M
Cohen, JS
Mardor, Y
Berman, E
Ringel, I
Citation: M. Sterin et al., Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: A P-31-magnetic resonance spectroscopy study, CANCER RES, 61(20), 2001, pp. 7536-7543
Authors:
Mardor, Y
Roth, Y
Lidar, Z
Jonas, T
Pfeffer, R
Maier, SE
Faibel, M
Nass, D
Hadani, M
Orenstein, A
Cohen, JS
Ram, Z
Citation: Y. Mardor et al., Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging, CANCER RES, 61(13), 2001, pp. 4971-4973
Citation: Mt. Ge et al., ADP ribosylation factor 6 binding to phosphatidylinositol 4,5-bisphosphate-containing vesicles creates defects in the bilayer structure: An electron spin resonance study, BIOPHYS J, 81(2), 2001, pp. 994-1005
Citation: Js. Cohen, Dose discrepancies between the Physicians' Desk Reference and the medical literature, and their possible role in the high incidence of dose-related adverse drug events, ARCH IN MED, 161(7), 2001, pp. 957-964
Citation: Js. Cohen, Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physicians' Desk Reference, ARCH IN MED, 161(6), 2001, pp. 880-885
Citation: Js. Cohen, Clinical and ethical concerns about switching patient treatment to "therapeutically interchangeable" medications, ARCH IN MED, 161(17), 2001, pp. 2153-2154
Citation: Js. Cohen, Clinical and laboratory improvement in ankylosing spondylitis after treatment with etanercept - A case report, JCR-J CLIN, 6(4), 2000, pp. 221-224
Citation: Js. Cohen, Multielectron effects in capture of antiprotons and muons by helium and neon - art. no. 022512, PHYS REV A, 6202(2), 2000, pp. 2512
Citation: Js. Cohen et al., The crochetage pattern in electrocardiograms of pediatric atrial septal defect patients, CAN J CARD, 16(10), 2000, pp. 1241-1247
Authors:
Singh, K
Mehta, K
Shaikh, NM
Tsai, JC
Moster, MR
Budenz, DL
Greenfield, DS
Chen, PP
Cohen, JS
Baerveldt, GS
Shaikh, S
Citation: K. Singh et al., Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil - Prospective randomized clinical trial, OPHTHALMOL, 107(12), 2000, pp. 2305-2309